SynthesisCells2022

Comparative Efficacy and Safety of Tezepelumab and Other Biologics in Patients with Inadequately Controlled Asthma According to Thresholds of Type 2 Inflammatory Biomarkers: A Systematic Review and Network Meta-Analysis.

Koichi Ando et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.